Skip to main content
OpenTrials
Completed

NCT Number: NCT02428673

Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients.

This study will use load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome).

Hypothesis: Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions such as cerebral palsy, spinal muscular atrophy, or other muscular dystrophies. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients.

Various modifications are added to assisted-standing devices to allow children with neuromuscular impairments to achieve standing postures. These customizations lead to load-sharing with the standing device, and consequently, a decrease in the amount of load passing through the lower extremities. Previous investigators developed custom-made load-measuring sensors to quantify the amount of load borne by the lower extremities while in passive standers, and found that the actual load varied from 23-102% of the child's body weight. These load-measuring sensors were specifically developed for restricted laboratory testing, rather than recording the load magnitude and duration of standing in any brand of standing device during daily use at home, school or therapy.

We previously developed load-sensing platforms that accurately measure loads experienced by the lower extremities of children with cerebral palsy in passive standers. These platforms can be incorporated into any stander design, are able to be used on a routine basis at a child's home, school or therapy, and are able to record the duration of weight-bearing to monitor compliance.

This study will use these load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must have a neuromuscular condition
  • Must be between 3-14 years old
  • Gross Motor Function Classification System (GMFCS) Level IV or V
  • Must be on a standing treatment program
  • Parent must be able to provide consent

Exclusion criteria

  • Currently taking bisphosphonates

Treatment and study plan

Assisted Standing Treatment Program

Other

Primary outcomes

  1. Bone Mineral Density (BMD) (measured by DXA)

    Time frame: 10 months

    Change from baseline in BMD, as , at 10 months.

  2. Bone Architecture (measured by pQCT)

    Time frame: 10 months

    Change from baseline in bone architecture, as measured by pQCT, at 10 months.

Secondary outcomes

  1. Pediatric Quality of Life Inventory (PedsQL)

    Time frame: 10 months

    Change from baseline in PedsQL scores at 10 months.

  2. Neuromuscular Module of the PedsQL

    Time frame: 10 months

    Change from baseline in PedsQL neuromuscular module scores at 10 months.

  3. Change in pulmonary function test

    Time frame: 10 months

    Change from baseline in pulmonary function at 10 months.

  4. Change in Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD)

    Time frame: 10 Months

    Change from baseline in CPCHILD score at 10 months.

Sponsors and collaborators

Lead sponsor

Gillette Children's Specialty Healthcare

Other

Registry information

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Apr 29, 2015
Registry last updated
Feb 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.